• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Previous Issues
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Benha Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 40 (2023)
Issue Issue 1
Issue Annual conference issue
Issue Special issue (Surgery)
Volume Volume 39 (2022)
Volume Volume 38 (2021)
Volume Volume 37 (2020)
Volume Volume 36 (2019)
Al Sayed, K., Elseaidy, A., Emara, N., amer, R., Soltan, M. (2023). Immunohistochemical study of (Arginase 1 and Glutamine synthetase) in Chronic hepatitis C, Cirrhosis and Hepatocellular carcinoma. Benha Medical Journal, 40(1), 275-287. doi: 10.21608/bmfj.2023.154807.1634
Kareem Gomaa Al Sayed; Adel Elseaidy; Nashwa Emara; ranih amer; Mervat M. Soltan. "Immunohistochemical study of (Arginase 1 and Glutamine synthetase) in Chronic hepatitis C, Cirrhosis and Hepatocellular carcinoma". Benha Medical Journal, 40, 1, 2023, 275-287. doi: 10.21608/bmfj.2023.154807.1634
Al Sayed, K., Elseaidy, A., Emara, N., amer, R., Soltan, M. (2023). 'Immunohistochemical study of (Arginase 1 and Glutamine synthetase) in Chronic hepatitis C, Cirrhosis and Hepatocellular carcinoma', Benha Medical Journal, 40(1), pp. 275-287. doi: 10.21608/bmfj.2023.154807.1634
Al Sayed, K., Elseaidy, A., Emara, N., amer, R., Soltan, M. Immunohistochemical study of (Arginase 1 and Glutamine synthetase) in Chronic hepatitis C, Cirrhosis and Hepatocellular carcinoma. Benha Medical Journal, 2023; 40(1): 275-287. doi: 10.21608/bmfj.2023.154807.1634

Immunohistochemical study of (Arginase 1 and Glutamine synthetase) in Chronic hepatitis C, Cirrhosis and Hepatocellular carcinoma

Article 413, Volume 40, Issue 1, May and June 2023, Page 275-287  XML PDF (744.15 K)
Document Type: Original Article
DOI: 10.21608/bmfj.2023.154807.1634
Authors
Kareem Gomaa Al Sayed email 1; Adel Elseaidy2; Nashwa Emara2; ranih amer3; Mervat M. Soltan4
1Department of Pathology
2Department of pathology faculty of medicin benha university
3Department of pathology faculty of medicin benha university
4Department of Pathology-National Liver Institute - Menofia University.
Abstract
Background: Morphological distinction of HCC among advanced chronic liver diseases still poses a number of problems. Definite diagnosis can’t be obtained by histologic evaluation alone in some cases, especially with small sample biopsies; in these cases, immunohistochemical staining is very useful. Therefore, more support is needed in the conventional pathological differentiation of HCC from chronic liver diseases, especially advanced cirrhosis and chronic hepatitis c.
Aim of the study: to assess the expression of Arginase 1 (Arg-1) and Glutamine synthetase (GS) in chronic hepatitis c, liver Cirrhosis and HCC to evaluate their role in differentiation between them.
Methods: A retrospective immunohistochemical study was performed on 74 liver cases; 17 cases of chronic hepatitis c, 25 cases of cirrhosis, and 32 cases of HCC. In addition to 8 cases of normal liver tissues obtained from donors for liver transplantation as a control group.
Results: There was negative statistical significant relation between type of lesion (chronic hepatitis C, cirrhosis and HCC group) and Arg-1 expression (P
Keywords
Arginase-1; Glutamine synthetase; Hepatocellular carcinoma; Chronic hepatitis C; Cirrhosis
Statistics
Article View: 25
PDF Download: 13
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.